{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:20:40Z","timestamp":1786360840325,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ejps.2016.09.015","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T16:46:19Z","timestamp":1473785179000},"page":"107-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Self-micellizing solid dispersion of cyclosporine A for pulmonary delivery: Physicochemical, pharmacokinetic and safety assessments"],"prefix":"10.1016","volume":"96","author":[{"given":"Hiroki","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kodai","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Mizumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7202-1853","authenticated-orcid":false,"given":"Hideyuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Onoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2016.09.015_bb0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0031-6997(24)01381-4","article-title":"Inflammatory mediators of asthma: an update","volume":"50","author":"Barnes","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2016.09.015_bb0010","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1073\/pnas.95.8.4760","article-title":"Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis-associated lung injury","volume":"95","author":"Bhatia","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2016.09.015_bb0015","first-page":"437","article-title":"Nephrotoxicity of cyclosporin A in hereditary hypertriglyceridemic rats","volume":"48","author":"Bohdanecka","year":"1999","journal-title":"Physiol. Res.\/Academia Scientiarum Bohemoslovaca"},{"key":"10.1016\/j.ejps.2016.09.015_bb0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF01986686","article-title":"Biological effects of cyclosporin A: a new antilymphocytic agent. 1976","volume":"43","author":"Borel","year":"1994","journal-title":"Agents Actions"},{"key":"10.1016\/j.ejps.2016.09.015_bb0025","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1345\/aph.140063","article-title":"Cyclosporine monitoring. 1986","volume":"41","author":"Burckart","year":"2007","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejps.2016.09.015_bb0030","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0270-9295(03)00090-1","article-title":"Cyclosporine nephrotoxicity","volume":"23","author":"Burdmann","year":"2003","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.ejps.2016.09.015_bb0035","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0169-409X(03)00078-4","article-title":"Novel alternative methods for the delivery of drugs for the treatment of asthma","volume":"55","author":"Chan","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2016.09.015_bb0040","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/adc.77.6.522","article-title":"The use of cyclosporin in corticosteroid dependent asthma","volume":"77","author":"Coren","year":"1997","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ejps.2016.09.015_bb0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2478\/s11658-008-0041-6","article-title":"Oral cyclosporine A\u2013the current picture of its liposomal and other delivery systems","volume":"14","author":"Czogalla","year":"2009","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.ejps.2016.09.015_bb0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0731-7085(95)01274-O","article-title":"Influence of cohesive properties of micronized drug powders on particle size analysis","volume":"13","author":"de Villiers","year":"1995","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2016.09.015_bb0055","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10653-011-9435-x","article-title":"Evaluating the respiratory bioaccessibility of nickel in soil through the use of a simulated lung fluid","volume":"34","author":"Drysdale","year":"2012","journal-title":"Environ. Geochem. Health"},{"key":"10.1016\/j.ejps.2016.09.015_bb0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1517\/17425247.1.1.67","article-title":"Dry powder inhalers for pulmonary drug delivery","volume":"1","author":"Frijlink","year":"2004","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2016.09.015_bb0065","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0031-3955(16)33215-1","article-title":"Clinical and physiological abnormalities in hepatic function","volume":"22","author":"Grand","year":"1975","journal-title":"Pediatr. Clin. N. Am."},{"key":"10.1016\/j.ejps.2016.09.015_bb0070","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/01.ccx.0000145095.90327.f2","article-title":"Biologic markers for the early detection of acute kidney injury","volume":"10","author":"Han","year":"2004","journal-title":"Curr. Opin. Crit. Care"},{"key":"10.1016\/j.ejps.2016.09.015_bb0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.2042-7158.1991.tb06688.x","article-title":"Unusual solubility behaviour of cyclosporin A in aqueous media","volume":"43","author":"Ismailos","year":"1991","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2016.09.015_bb0080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13556-013-0003-9","article-title":"Fine particle profile of fluticasone propionate\/formoterol fumarate versus other combination products: the DIFFUSE study","volume":"3","author":"Johal","year":"2013","journal-title":"Comb. Prod. Ther."},{"key":"10.1016\/j.ejps.2016.09.015_bb0085","doi-asserted-by":"crossref","first-page":"248s","DOI":"10.1016\/j.transproceed.2003.12.040","article-title":"Cyclosporine-A-based immunosuppression and renal functional reserve in organ-transplant patients","volume":"36","author":"Kamar","year":"2004","journal-title":"Transplantation proceedings"},{"key":"10.1016\/j.ejps.2016.09.015_bb0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2133\/dmpk.DMPK-10-RG-070","article-title":"Enhancement of drug solubility and absorption by copolymers of 2-methacryloyloxyethyl phosphorylcholine and n-butyl methacrylate","volume":"26","author":"Kano","year":"2011","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2016.09.015_bb0095","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1164\/rccm.200607-940OC","article-title":"An investigation of airway acidification in asthma using induced sputum: a study of feasibility and correlation","volume":"175","author":"Kodric","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejps.2016.09.015_bb0100","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/S0041-1345(00)01535-9","article-title":"The beneficial effect of melatonin for cyclosporine hepatotoxicity in rats","volume":"32","author":"Kwak","year":"2000","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejps.2016.09.015_bb0105","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","article-title":"Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2016.09.015_bb0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0165-2478(00)00200-5","article-title":"Pulmonary function changes and increased Th-2 cytokine expression and nuclear factor kB activation in the lung after sensitization and allergen challenge in brown Norway rats","volume":"73","author":"Lin","year":"2000","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ejps.2016.09.015_bb0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ejps.2009.04.002","article-title":"Novel dry powder formulation of ovalbumin for development of COPD-like animal model: physicochemical characterization and biomarker profiling in rats","volume":"37","author":"Misaka","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2016.09.015_bb0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1465-9921-7-10","article-title":"Mucociliary and long-term particle clearance in airways of patients with immotile cilia","volume":"7","author":"Moller","year":"2006","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejps.2016.09.015_bb0125","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1183\/09031936.95.08071091","article-title":"Treatment of steroid-dependent bronchial asthma with cyclosporin","volume":"8","author":"Nizankowska","year":"1995","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejps.2016.09.015_bb0130","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejps.2013.05.014","article-title":"Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects","volume":"49","author":"Onoue","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2016.09.015_bb0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejps.2014.05.006","article-title":"Self-micellizing solid dispersion of cyclosporine A with improved dissolution and oral bioavailability","volume":"62","author":"Onoue","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2016.09.015_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067976","article-title":"Measuring myeloperoxidase activity in biological samples","volume":"8","author":"Pulli","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2016.09.015_bb0145","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1152\/jappl.1986.60.2.532","article-title":"Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution","volume":"60","author":"Rennard","year":"1986","journal-title":"J. Appl. Physiol. (Bethesda, Md.: 1985)"},{"key":"10.1016\/j.ejps.2016.09.015_bb0150","doi-asserted-by":"crossref","first-page":"8979","DOI":"10.3390\/ijms15058979","article-title":"Transition from cyclosporine-induced renal dysfunction to nephrotoxicity in an in vivo rat model","volume":"15","author":"Sereno","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2016.09.015_bb0155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijpharm.2015.12.065","article-title":"Strategic application of self-micellizing solid dispersion technology to respirable powder formulation of tranilast for improved therapeutic potential","volume":"499","author":"Suzuki","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.09.015_bb0160","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-2999(01)00975-X","article-title":"Effects of cyclosporin a administered into the airways against antigen-induced airway inflammation and hyperreactivity in the rat","volume":"420","author":"Underwood","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2016.09.015_bb0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1699-0463.1995.tb01125.x","article-title":"Some new aspects of molecular mechanisms of cyclosporin A effect on immune response","volume":"103","author":"Zav'yalov","year":"1995","journal-title":"APMIS"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716303803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716303803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:32:10Z","timestamp":1749580330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098716303803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":33,"alternative-id":["S0928098716303803"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2016.09.015","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-micellizing solid dispersion of cyclosporine A for pulmonary delivery: Physicochemical, pharmacokinetic and safety assessments","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2016.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}